These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23502781)

  • 1. Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension.
    Germain M; Eyries M; Montani D; Poirier O; Girerd B; Dorfmüller P; Coulet F; Nadaud S; Maugenre S; Guignabert C; Carpentier W; Vonk-Noordegraaf A; Lévy M; Chaouat A; Lambert JC; Bertrand M; Dupuy AM; Letenneur L; Lathrop M; Amouyel P; de Ravel TJ; Delcroix M; Austin ED; Robbins IM; Hemnes AR; Loyd JE; Berman-Rosenzweig E; Barst RJ; Chung WK; Simonneau G; Trégouët DA; Humbert M; Soubrier F
    Nat Genet; 2013 May; 45(5):518-21. PubMed ID: 23502781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression Quantitative Trait Locus Mapping in Pulmonary Arterial Hypertension.
    Ulrich A; Otero-Núñez P; Wharton J; Swietlik EM; Gräf S; Morrell NW; Wang D; Lawrie A; Wilkins MR; Prokopenko I; Rhodes CJ; Consortium OBOTNBD; Consortium UPCS
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33105808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic ablation of the BMPR2 gene in pulmonary endothelium is sufficient to predispose to pulmonary arterial hypertension.
    Hong KH; Lee YJ; Lee E; Park SO; Han C; Beppu H; Li E; Raizada MK; Bloch KD; Oh SP
    Circulation; 2008 Aug; 118(7):722-30. PubMed ID: 18663089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.
    Hemnes AR; Zhao M; West J; Newman JH; Rich S; Archer SL; Robbins IM; Blackwell TS; Cogan J; Loyd JE; Zhao Z; Gaskill C; Jetter C; Kropski JA; Majka SM; Austin ED
    Am J Respir Crit Care Med; 2016 Aug; 194(4):464-75. PubMed ID: 26926454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and the molecular pathogenesis of pulmonary arterial hypertension.
    Liu D; Morrell NW
    Curr Hypertens Rep; 2013 Dec; 15(6):632-7. PubMed ID: 24078385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic linkage analysis of a large family identifies
    Puigdevall P; Piccari L; Blanco I; Barberà JA; Geiger D; Badenas C; Milà M; Castelo R; Madrigal I
    J Med Genet; 2019 Jul; 56(7):481-490. PubMed ID: 30894412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
    Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
    J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome-wide association analysis identifies
    Kimura M; Tamura Y; Guignabert C; Takei M; Kosaki K; Tanabe N; Tatsumi K; Saji T; Satoh T; Kataoka M; Kamitsuji S; Kamatani N; Thuillet R; Tu L; Humbert M; Fukuda K; Sano M
    Oncotarget; 2017 Sep; 8(43):74917-74926. PubMed ID: 29088834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in genome-wide association study of pulmonary arterial hypertension].
    Zhu ZQ; Sun XL; Chen X; Anniwaer A; Wang MY; Yang SQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):813-818. PubMed ID: 35927052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment.
    Jonigk D; Golpon H; Bockmeyer CL; Maegel L; Hoeper MM; Gottlieb J; Nickel N; Hussein K; Maus U; Lehmann U; Janciauskiene S; Welte T; Haverich A; Rische J; Kreipe H; Laenger F
    Am J Pathol; 2011 Jul; 179(1):167-79. PubMed ID: 21703400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.
    Song Y; Coleman L; Shi J; Beppu H; Sato K; Walsh K; Loscalzo J; Zhang YY
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H677-90. PubMed ID: 18552156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
    Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
    Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.
    Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW
    Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension.
    Aldred MA; Vijayakrishnan J; James V; Soubrier F; Gomez-Sanchez MA; Martensson G; Galie N; Manes A; Corris P; Simonneau G; Humbert M; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):212-3. PubMed ID: 16429403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pri-microRNA-124 rs531564 polymorphism minor allele increases the risk of pulmonary artery hypertension by abnormally enhancing proliferation of pulmonary artery smooth muscle cells.
    Li Q; Qian Z; Wang L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1351-1361. PubMed ID: 28496318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of pulmonary arterial hypertension: current understanding and future directions.
    Newman JH; Trembath RC; Morse JA; Grunig E; Loyd JE; Adnot S; Coccolo F; Ventura C; Phillips JA; Knowles JA; Janssen B; Eickelberg O; Eddahibi S; Herve P; Nichols WC; Elliott G
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):33S-39S. PubMed ID: 15194176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
    Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
    Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.